Dasa Genomics

What Dasa Genomics does

Dasa Genômica (Dasa Genomics) is the specialized genomic medicine brand of Dasa, the largest integrated health network in Brazil. Established in 2017, the company offers a portfolio of more than 750 genetic and genomic tests across 9 medical specialties, including oncology, onco-hematology, rare diseases and neurology, reproductive health and fetal medicine, cardiology, ophthalmology, pharmacogenomics, and infectious diseases. Differentiated assays in the catalog include Signatera for circulating tumor DNA monitoring, MethylBrain for brain tumor methylation classification, Endopredict for breast cancer recurrence risk, expanded NIPT covering 92 microdeletion syndromes, Karius plasma metagenomics for identifying over 1,000 pathogens, PharmOne pharmacogenomics, and comprehensive exome sequencing.

Underlying the portfolio is a multi-modality laboratory platform spanning Next-Generation Sequencing (NGS), MLPA, real-time PCR, DNA microarray/CGH array, and methylation profiling, supported by PALC and CAP international accreditations. The lab operates as part of the Dasa diagnostic ecosystem of 45+ brands (including Sérgio Franco, Delboni, Lavoisier, and Alta) with 900+ service points across Brazil, and extends selected services into Latin America through regional partnerships. Direct digital access is provided through the NAV patient platform and NavPro physician portal, with WhatsApp-based scheduling and a Núcleo de Assessoria Médica (NAM) channel for clinical support.

The business model combines one-time clinical testing fees (private pay and ANS-covered), B2B laboratory services routed through the Dasa brand network, and physician-driven test ordering through NavPro and NAM. Customer concentration is structurally diversified across patient pay, private health plans, and B2B channels, though operational dependence on the parent Dasa ecosystem is the primary concentration risk. The company does not publicly disclose pricing or standalone revenue.

Name

Dasa Genomics

Legal name

Dasa Genômica

Website

https://dasagenomica.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Dasa Genômica is the genomic medicine division of Dasa, Brazil's largest integrated health network. It delivers 750+ genetic and genomic tests across 9 specialties through a 900-point national service network serving patients, physicians, and health plans.

Ownership category

akta.pro rank

Product category

Clinical Genomic Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Newborn Screening & Genetic Public Health Laboratories (HLAJAIAJ)

Keywords

• Clinical genomic diagnostics
• Next-generation sequencing
• Non-invasive prenatal testing
• Pharmacogenomic testing
• Oncology molecular profiling

Headquarters

HQ city

Indianópolis

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Genetic Testing Services: Dasa Genômica generates revenue through clinical laboratory testing services, offering over 750 genetic and genomic tests across 9 medical specialties. Revenue comes from both private pay patients and insurance/health plan coverage (ANS) for eligible tests.
2. B2B Laboratory Services: Services provided through a network of 45+ diagnostic brands including Sérgio Franco, Delboni, Lavoisier, and Alta, enabling wide distribution across Brazil's healthcare system.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Dasa Genômica is a clinical genomic diagnostics laboratory offering more than 750 genetic and genomic tests across nine medical specialties, including oncology, reproductive health, rare diseases, pharmacogenomics, cardiogenetics, ophthalmogenetics, and infectious disease. Tests are delivered through a network of more than 900 service points across Brazil under 45+ diagnostic brands, supported by a digital consumer platform (NAV) for patients and a physician portal (NavPro) plus a Medical Advisory Center (NAM) for healthcare providers. The laboratory holds PALC and CAP international accreditations and operates within Dasa, Brazil's largest integrated health network.

Product overview

Dasa Genômica is a specialized genomic medicine company offering more than 750 genetic and genomic tests across multiple medical specialties. The portfolio includes pharmacogenetic tests (PharmOne), prenatal screening (NIPT Básico, NIPT Ampliado, Sexagem Fetal, PregnancyLoss), neonatal screening (Baby Genes), oncology tests (Signatera, Methylbrain, Endopredict), comprehensive exome sequencing, and specialized panels for cardiogenetics, ophthalmogenetics, and infectious diseases (Karius Teste). The company's offerings span 9 medical specialty areas including oncology, onco-hematology, pharmacogenomics, rare diseases and neurology, reproductive health, fetal medicine, cardiology, ophthalmology, and immunology/infectiology. Tests are performed using advanced technologies including Next-Generation Sequencing (NGS), MLPA, real-time PCR, methylation analysis, and metagenomics.

Differentiator

Problem solved

Functional benefit

Products and services

• PharmOne - Painel Farmacogenético Completo A pharmacogenetic test that helps physicians prescribe the most appropriate and safe drug treatment by analyzing genetic variants that affect drug metabolism. Targeted at clinicians treating patients where adverse drug reactions or medication inefficacy are a concern.
• Triagem Neonatal por NGS - Baby Genes Neonatal genetic screening using NGS that detects genetic diseases including inborn errors of metabolism, immunological, renal, and endocrine alterations. Targeted at newborns and pediatric patients.
• Signatera - Exoma Tumoral Tumor-informed molecular residual disease test that detects circulating tumor DNA (ctDNA) using a tumor-specific genetic signature to monitor for disease recurrence and inform therapeutic decisions. Targeted at oncology patients and their treating physicians.
• Sexagem Fetal Non-invasive test that determines fetal sex from the 8th week of gestation by using real-time PCR to identify Y-chromosome sequences in fetal cells present in maternal blood. Targeted at expectant mothers seeking early fetal sex determination.
• Methylbrain DNA methylation profiling test for diagnosing and classifying brain tumors, evaluating methylation class, 1p/19q codeletion, and MGMT promoter methylation status. Targeted at neuro-oncology patients and their treating physicians.
• Endopredict - Câncer de Mama Prognostic and predictive test that estimates the risk of breast cancer recurrence up to 15 years. Targeted at breast cancer patients and oncologists making treatment decisions about chemotherapy.
• Sequenciamento do Exoma Complete exome sequencing that analyzes the coding regions (exons) of approximately 22,000 genes to identify variants potentially causing disease. Targeted at patients with suspected rare genetic disorders and undiagnosed diseases.
• PregnancyLoss Advanced test that investigates whether an underlying genetic cause exists in cases of spontaneous pregnancy loss by analyzing fetal DNA in maternal blood. Targeted at couples experiencing recurrent or unexplained pregnancy loss.
• Karius Teste Genomic metagenomic test for etiological diagnosis of infectious diseases that identifies more than 1,000 types of pathogens (bacteria, viruses, and fungi) from plasma samples using NGS. Targeted at patients with difficult-to-diagnose infections and immunocompromised patients.
• NIPT Ampliado Expanded non-invasive prenatal test detecting 92 microdeletions and microduplications, including basic NIPT analyses plus additional rare microdeletion syndromes. Targeted at expectant mothers seeking comprehensive prenatal chromosomal screening.
• NIPT Básico Basic non-invasive prenatal test screening for common trisomies (13, 18, 21), sex chromosome aneuploidies, 22q11.2 microdeletion, and triploidy, with optional fetal sex determination. Targeted at expectant mothers seeking standard prenatal chromosomal screening.
• Deleções e Duplicações no Gene RB1 - MLPA MLPA-based test for copy-number variation analysis in the RB1 gene associated with retinoblastoma, a malignant neoplasia of the retina. Targeted at patients with suspected retinoblastoma and their families for hereditary risk assessment.
• Painel NGS para Dislipidemias Familiares NGS panel for the investigation of monogenic forms of dyslipidemias, especially familial hypercholesterolemia, enabling precise etiological diagnosis and personalized therapeutic management. Targeted at cardiologists and patients with suspected hereditary lipid disorders.

Quantifiable outcome

• More than 750 genetic and genomic tests available
• +3 more outcomes

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Sérgio FrancocoreChannel Partner/ Reseller/ DistributorMajor Brazilian diagnostic brand operating as part of the Dasa network, providing access to Dasa Genômica's genetic testing services through their extensive laboratory infrastructure.
• DelbonicoreChannel Partner/ Reseller/ DistributorLeading Brazilian diagnostic brand integrated into the Dasa ecosystem, offering Dasa Genômica's genetic testing portfolio through their service network.
• LavoisiercoreChannel Partner/ Reseller/ DistributorBrazilian diagnostic brand operating within the Dasa network, distributing Dasa Genômica's genetic testing services.
• AltacoreChannel Partner/ Reseller/ DistributorBrazilian diagnostic brand integrated into Dasa's network, providing access points for Dasa Genômica's genetic testing services.
• Dasa Ecosystem (45+ brands)coreChannel Partner/ Reseller/ DistributorDasa Genômica operates within the Dasa diagnostic ecosystem comprising 45+ brands, collectively providing 900+ service points for genetic testing access across Brazil. Includes Sérgio Franco, Delboni, Lavoisier, Alta, and other regional brands.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• NeoGenomics: US oncology-focused clinical lab offering NGS tumor profiling, liquid biopsy, and hereditary cancer testing; comparable in oncology genomics menu to Dasa Genômica's oncology segment.
• Centogene: Germany-headquartered rare disease genomics lab with exome/genome diagnostics; comparable in rare disease and hereditary testing to Dasa Genômica's rare diseases portfolio.

Others

• Karius: US-based liquid biopsy company specializing in plasma metagenomic pathogen detection; technology partner of Dasa Genômica (offered as "Karius Teste") and an adjacent peer in infectious disease genomics.

Regional players

• Laboratório Sabin: Major Brazilian diagnostic network with growing genetics and genomic testing menu; competes with Dasa Genômica in central Brazil and overlapping specialty segments.

Broad incumbents

• Myriad Genetics: US-based genetic testing company offering oncology (incl. Endopredict), pharmacogenomic, and hereditary cancer tests; technology partner of Dasa Genômica and a global competitor.
• Invitae (now Labcorp): Global genetic testing company (now part of Labcorp) with broad hereditary cancer, rare disease, and reproductive genetics menus; potential competitor as Labcorp expands internationally.
• Natera: US-based leader in NIPT, oncology molecular residual disease (Signatera), and reproductive genetics. Comparable in technology platforms; competes as international player expanding into Latin America.
• Igenomix: Global reproductive genetics lab with strong presence in Latin America offering NIPT, carrier screening, and preimplantation genetics. Competes with Dasa Genômica's reproductive health segment.

Direct peers

• Mendelics Análise Genômica: Brazilian genomics laboratory offering clinical exome, NIPT, oncology panels, and pharmacogenomics. Direct head-to-head competitor in the Brazilian genomic testing market with overlapping menus.
• Laboratório Fleury: One of Brazil's largest diagnostic medicine networks offering a broad portfolio including genetic and genomic testing across oncology, reproductive health, and rare diseases through its own service network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/dasagenomica
• LinkedInlinkedin.com/company/dasagenomica

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dasa Genomics